List your tool

Head to head · 2026

SOPHiA GENETICS vs Tempus AI

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

SOPHiA GENETICS

AI genomic analytics at 98-99% accuracy, deployed across 1,000+ healthcare institutions in 75+ countries - 2.6…

3.9Not listed

Visit SOPHiA GENETICS (opens SOPHiA GENETICS in a new tab)

Tempus AI

Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue

4.3Not listed

Visit Tempus AI (opens Tempus AI in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: SOPHiA GENETICS does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Tempus AI

    3.9 against 4.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onSOPHiA GENETICSTempus AI
Our rating3.94.3Better
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • SOPHiA DDM - AI genomic and radiomic analysis platform
  • 98-99% accuracy across 2.6M+ analyzed genomic profiles
  • Oncology coverage - solid tumors, blood cancers, hereditary cancers, liquid biopsy
  • Rare and inherited disorder analysis
  • HIPAA/GDPR-compliant cloud infrastructure
  • Machine learning applied to genomic and clinical data for precision treatment matching
  • One of the largest connected libraries of clinical and molecular data
  • Publicly traded on Nasdaq under the ticker TEM
  • Q1 2026 revenue of $348.1M, up 36.1% year over year
  • 2026 revenue guidance raised to $1.59-$1.60 billion
Pros
  • Accuracy claims are backed by scale (2.6M+ profiles), not a small validation sample
  • Deployed across a genuinely large, verifiable institutional network (1,000+ sites, 75+ countries)
  • Covers both oncology and rare/inherited disorder use cases
  • Publicly reported financials give unusual transparency into scale and growth
  • Massive, growing data library strengthens precision-matching over time
  • Strong, consistent revenue growth across both diagnostics and data segments
Cons
  • No published pricing - an institutional sales process
  • Built for healthcare institutions, not individual practitioners or patients directly
  • Requires integration into existing clinical genomics/pathology workflows
  • Pricing runs through insurance billing and enterprise agreements, not published rates
  • Built specifically for precision medicine and oncology, a narrower clinical scope
  • Best suited to institutions already positioned to act on genomic testing results
CompanySOPHiA GENETICSTempus AI, founded 2015

Prices come from each vendor's pricing page, last checked 20260824. Check the vendor before you buy.

FAQ

Questions people ask

Is SOPHiA GENETICS better than Tempus AI?

In our reviews SOPHiA GENETICS scores 3.9 and Tempus AI scores 4.3. The better pick depends on the job. SOPHiA GENETICS: AI genomic analytics at 98-99% accuracy, deployed across 1,000+ healthcare institutions in 75+ countries - 2.6 million-plus genomic profiles analyzed to date. Tempus AI: Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue.

Which is cheaper, SOPHiA GENETICS or Tempus AI?

SOPHiA GENETICS: see pricing. Tempus AI: see pricing.

Do SOPHiA GENETICS and Tempus AI have free plans?

Neither lists a free plan.

More comparisons